decemb
cluster
acut
respiratori
ill
known
pneumonia
occur
wuhan
china
world
health
organ
declar
rapidli
spread
coronaviru
outbreak
pandem
march
acknowledg
seem
clear
time
viru
like
spread
countri
globe
februari
chines
center
diseas
control
prevent
china
cdc
offici
report
asymptomat
case
death
case
mild
case
among
confirm
case
male
femal
lymphopenia
particular
lymphopenia
common
among
patient
observ
notabl
drop
lymphocyt
count
occur
earli
cours
syndrom
associ
advers
outcom
appear
phenomenon
lymphocyt
deplet
pld
suggest
sever
advers
outcom
outcom
observ
discharg
die
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
decemb
cluster
acut
respiratori
ill
known
pneumonia
occur
wuhan
china
world
health
organ
declar
rapidli
spread
coronaviru
outbreak
pandem
march
acknowledg
seem
clear
time
viru
like
spread
countri
globe
februari
chines
center
diseas
control
prevent
china
cdc
offici
report
asymptomat
case
death
case
mild
case
among
confirm
case
male
femal
januari
novel
coronaviru
identifi
sampl
bronchoalveolar
lavag
fluid
patient
wuhan
confirm
caus
pneumonia
fullgenom
sequenc
phylogen
analysi
indic
distinct
clade
betacoronavirus
associ
human
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
spread
rapidli
sinc
first
identifi
wuhan
shown
wide
spectrum
sever
recent
report
show
sarscov
share
function
hostcel
receptor
angiotensinconvert
enzym
furthermor
bind
receptor
fold
higher
affin
sarscov
bind
receptor
anoth
report
show
cell
entri
depend
sinc
receptor
lung
alveolar
epitheli
cell
enterocyt
small
intestin
domin
lung
alveolar
epitheli
cell
enterocyt
small
intestin
may
import
suscept
factor
human
accord
world
health
organ
interim
guidanc
januari
infect
classifi
asymptomat
case
mild
sever
case
pneumonia
critic
case
pneumonia
ard
sepsi
septic
shock
sever
case
pneumonia
defin
patient
respiratori
rate
breathsmin
sever
respiratori
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
infect
cluster
within
group
human
close
contact
like
affect
older
men
comorbid
howev
dynam
profil
infect
risk
factor
associ
pneumonia
fulli
known
written
inform
consent
waiv
due
rapid
emerg
infecti
diseas
identif
patient
achiev
review
analyz
avail
electron
medic
record
patient
care
resourc
retrospect
analyz
patient
accord
interim
guidanc
laboratori
confirm
infect
perform
previous
describ
confirm
case
defin
posit
result
high
throughput
sequenc
realtim
reversetranscriptasepolymerasechainreact
rtpcr
assay
pharyng
swab
specimen
sampl
collect
extract
rna
patient
suspect
infect
describ
previous
brief
pharyng
swab
place
collect
tube
viru
preserv
solut
total
rna
extract
within
hour
use
respiratori
sampl
rna
isol
kit
forti
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
cell
lysat
transfer
collect
tube
follow
vortex
second
stand
room
temperatur
minut
collect
tube
centrifug
rpmmin
minut
suspens
use
rtpcr
assay
rna
two
target
gene
includ
open
read
frame
nucleocapsid
protein
n
simultan
amplifi
test
rtpcr
assay
target
goat
antihuman
igg
igm
purchas
thermofish
inc
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
aunprabbitigg
sampl
pad
pretreat
bsa
wv
wv
use
continu
research
observ
previou
patient
lymphopenia
includ
male
femal
patient
patient
receiv
broad
spectrum
antibiot
patient
receiv
oseltamivir
lopinavirritonavir
intraven
methylprednisolon
high
dosag
use
patient
respiratori
distress
progress
consolid
chest
radiograph
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
patient
requir
oxygen
support
hospit
tabl
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
subset
peripher
blood
lymphocyt
patient
analyz
patient
reduc
cell
count
earli
phase
ill
reach
trough
day
recov
gradual
afterward
figur
ratio
cell
remain
normal
rang
b
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
c
figur
lymphocyt
subset
peripher
blood
day
ill
patient
xaxi
repres
day
yaxi
repres
cellsmm
lymphocyt
subset
patient
patient
recov
day
compar
patient
lead
pld
till
death
occur
figur
b
c
abnorm
lymphocyt
variabl
common
among
patient
new
respiratori
ill
known
caus
pandem
worldwid
lymphopenia
deplet
lymphocyt
subset
pld
may
associ
diseas
sever
link
mortal
studi
effect
variou
bodi
system
crucial
understand
diseas
due
one
transfer
patient
studi
hospit
coinfect
influenza
viru
day
observ
nine
patient
test
addit
respiratori
pathogen
patient
alreadi
treat
oseltamivir
lopinavirritonavir
admiss
test
neg
patient
test
posit
igm
influenza
viru
oseltamivir
lopinavirritonavir
treatment
ad
day
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
observ
patient
test
posit
igm
igg
influenza
viru
day
observ
without
treatment
antivir
therapi
due
poor
renal
function
sensit
igg
igm
assay
test
day
observ
nonsurvivor
suggest
b
cell
function
still
intact
nonsurvivor
lymphopenia
particular
lymphopenia
common
among
patient
observ
notabl
drop
lymphocyt
count
occur
earli
cours
syndrom
associ
advers
outcom
appear
phenomenon
lymphocyt
deplet
pld
suggest
sever
advers
outcom
outcom
observ
discharg
die
studi
first
observ
patient
coinfect
influenza
viru
studi
evalu
mechan
manifest
may
help
us
understand
full
pictur
diseas
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
